Stay updated on Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial
Sign up to get notified when there's something new on the Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial page.

Latest updates to the Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedRevision updated to v3.4.2. The prior funding-status notice and revision v3.4.1 were removed.SummaryDifference0.4%

- Check21 days agoChange DetectedA site-wide notice about government funding and NIH Clinical Center operating status has been added, with links to cc.nih.gov and opm.gov. A revision note updated the site version from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check28 days agoChange DetectedGlossary toggle added to the page. Footer metadata updated to include 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and revision 'v3.4.0'; the previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and revision 'v3.3.4' were removed.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision tag updated to v3.3.4, replacing v3.3.3; no changes to the study details, eligibility criteria, or outcomes.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded a Locations section with a California site for the study; page revision updated to v3.3.3.SummaryDifference0.2%

- Check85 days agoChange DetectedFooter revision tag updated from v3.3.1 to v3.3.2; no other visible content changes are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial page.